# Spider Versus Emboshield Distal Protection on Cerebral Microembolization During Vulnerable Plaque in Carotid Artery Stenting

> **NCT04904250** · NA · UNKNOWN · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 172 (estimated)

## Conditions studied

- Stroke
- Carotid Stenosis
- Carotid Artery Stent

## Interventions

- **DEVICE:** Emboshield
- **DEVICE:** Spider

## Key facts

- **NCT ID:** NCT04904250
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-27
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-10-01
- **Target enrollment:** 172 (ESTIMATED)
- **Last updated:** 2022-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04904250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04904250, "Spider Versus Emboshield Distal Protection on Cerebral Microembolization During Vulnerable Plaque in Carotid Artery Stenting". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT04904250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*